Data on the association of serum glypican-4 with future major adverse cardiovascular events and mortality in patients undergoing coronary angiography
- DOI
- 10.1016/j.dib.2022.108142
- Published
- 2022-06
- Container
- Data in Brief
- Publisher
- Elsevier BV
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1016/j.dib.2022.108142,
title = {Data on the association of serum glypican-4 with future major adverse cardiovascular events and mortality in patients undergoing coronary angiography},
author = {Axel Muendlein and Eva Maria Brandtner and Andreas Leiherer and Kathrin Geiger and Christine Heinzle and Stella Gaenger and Peter Fraunberger and Arthur Mader and Christoph H. Saely and Heinz Drexel},
year = {2022},
journal = {Data in Brief},
doi = {10.1016/j.dib.2022.108142},
url = {https://doi.org/10.1016/j.dib.2022.108142}
}RIS
TY - JOUR TI - Data on the association of serum glypican-4 with future major adverse cardiovascular events and mortality in patients undergoing coronary angiography AU - Axel Muendlein AU - Eva Maria Brandtner AU - Andreas Leiherer AU - Kathrin Geiger AU - Christine Heinzle AU - Stella Gaenger AU - Peter Fraunberger AU - Arthur Mader AU - Christoph H. Saely AU - Heinz Drexel PY - 2022 JO - Data in Brief DO - 10.1016/j.dib.2022.108142 UR - https://doi.org/10.1016/j.dib.2022.108142 ER -
APA
Muendlein, A., Brandtner, E. M., Leiherer, A., Geiger, K., Heinzle, C., Gaenger, S., Fraunberger, P., Mader, A., Saely, C. H., & Drexel, H. (2022). Data on the association of serum glypican-4 with future major adverse cardiovascular events and mortality in patients undergoing coronary angiography. Data in Brief. https://doi.org/10.1016/j.dib.2022.108142
Source records
- crossref · retrieved 2026-09-26T07:34:55.023Z